Dyadic receives US patent for its C1 platform technology fungal strains

In Florida, the United States Patent and Trademark Office issued Dyadic International, Inc. the U.S. Patent No. 8,268,585 entitled, “Transformation System in the Field of Filamentous Fungal Hosts”. The patent covers methods of developing, programming and growing improved strains of fungus that make up Dyadic’s C1 platform technology. It also covers the construction and use of C1 strains for the economical over-production of enzymes and other proteins at industrial scale for numerous applications including food, animal feed, fuels, pharmaceuticals, as well as organic acids and antibiotics.